NGM Biopharmaceuticals

+$0.60 (+2.14%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NGM and other stocks, options, and ETFs commission-free!

About NGM

NGM Biopharmaceuticals, Inc. Common Stock, also called NGM Biopharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases.

CEO
David J. Woodhouse
Employees
210
Headquarters
South San Francisco, California
Founded
2007

NGM Key Statistics

Market Cap
2.13B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
144.96K
High Today
$29.20
Low Today
$27.65
Open Price
$28.03
Volume
169.36K
52 Week High
$32.12
52 Week Low
$14.93

NGM Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.42 per share
Actual
-$0.36 per share

You May Also Like

NVCR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure